Commentary
Video
Author(s):
Haley M. Hill, PA-C, discusses current approaches and treatment challenges in NRG1-positive non–small cell lung cancer and pancreatic cancer.
Perioperative Vorasidenib and Ivosidenib Remain Effective, Safe in IDH1+ Diffuse Glioma
Ongoing Research Advances Equity and Precision Oncology Through Tissue-Agnostic Therapies: With Chandler Park, MD, and Vivek Subbiah, MD
FDA Approves Oral Solution of Imatinib for Certain Leukemias, Others Cancers
How to Apply Research Developments in ALK-Positive NSCLC: With Chandler Park, MD, and Tejas Patil, MD
Adding an HPK1 Inhibitor to Immune Checkpoint Inhibition May Be Effective in Solid Tumors
Ongoing Research Could Help Define the Role of Immunotherapy in Earlier-Stage HCC
Mirdametinib Improves HRQOL in Adult and Pediatric Patients With NF1-PN
Dr Schiff on PFS and OS Data With Temozolomide Plus Radiation in Grade II Glioma
Larotrectinib Induces Rapid, Durable Responses in Pediatric Patients With TRK Fusion+ CNS Tumors